Securities code: 002513 securities abbreviation: Jiangsu Lanfeng Bio-Chemical Co.Ltd(002513) Announcement No.: 2022-017 Jiangsu Lanfeng Bio-Chemical Co.Ltd(002513)
2021 annual performance forecast
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
1、 Performance forecast
1. Performance forecast period: from January 1, 2021 to December 31, 2021.
2. Expected operating performance: □ loss \uf0a3 turning loss into profit □ rising in the same direction □ falling in the same direction
The current reporting period of the project is the same period of last year
Loss attributable to shares of listed companies: 550 million yuan – 45 million yuan, profit: net profit of 14.8236 million yuan
Net profit after deducting non recurring profit and loss: 540 million yuan – 460 million yuan loss: 47.5746 million yuan
Basic earnings per share loss: 1.62 yuan / share – 1.32 yuan / share profit: 0.04 yuan / share
2、 Performance forecast and pre audit
The relevant data of this performance forecast is the result of the preliminary calculation of the company. The company has pre communicated with the annual audit accounting firm on matters related to the performance forecast. There is no major difference between the two sides, and the specific data shall be subject to the audit results.
3、 Explanation of performance change reasons
1. During the reporting period, due to the impairment of phosgene and phosgene products and some related idle fixed assets, the impairment loss of fixed assets is large.
2. During the reporting period, the prices of upstream raw materials continued to rise sharply, resulting in an increase in the production costs of the company’s main products. Due to fierce industry competition, the increase in the company’s production costs could not be effectively transmitted to downstream customers, which had a certain impact on the company’s operating profits.
3. Affected by the repeated epidemic situation outside China, environmental protection, double control of power and production restriction and other policies, the overall production of the company in 2021 was unstable, the capacity utilization rate was also greatly affected, at a low level, the production cost of products was also increased, further reducing the gross profit margin of products, and then increasing the loss of the company.
4. With the increasingly strict national requirements on safety and environmental protection of chemical enterprises, the company has increased the investment in safety and environmental protection in this period, thus increasing the overall cost and production cost of the company.
The above reasons have a great impact on the company’s performance in 2021. The company will actively take countermeasures, accelerate the pace of transformation and upgrading, actively explore the market, strengthen cost control, improve the operation efficiency of the company, enhance the profitability of products, and strive to improve the overall business performance of the company.
4、 Other relevant instructions
This performance forecast is the preliminary calculation result of the company’s financial department, which has not been audited by the audit institution. The specific financial data shall be subject to the 2021 annual report disclosed by the company. Please make careful decisions and pay attention to investment risks.
It is hereby announced.
Jiangsu Lanfeng Bio-Chemical Co.Ltd(002513) board of directors January 28, 2022
